The Neuroscience Report—Volume 39 (April 11, 2016): Rapid-acting Antidepressants

| April 11, 2016 | 0 Comments

Neuroscience_Report_logo


The latest in neuroscience—sorted and summarized for you


Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information.

This week’s topic: Rapid-acting Antidepressants


Journal Articles

Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants

Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy

Neurobiology of Stress, Depression, and Rapid Acting Antidepressants: Remodeling Synaptic Connections

Circadian Dysregulation of Clock Genes: Clues to Rapid Treatments in Major Depressive Disorder

Ketamine and Other N-methyl-D-aspartate Receptor Antagonists in the Treatment of Depression: A Perspective Review


News Articles

Scientists Seek Fast-acting Antidepressant, from Ketamine to Laughing Gas

Five New NMDA Receptor (Glutamate) Modulators For Depression

Rapastinel: A Novel Approach to Depression?

The Search for a “Safer” Ketamine

Novel Route for Ketamine in the Treatment of MDD


Wildcards

20 New Antidepressants In The Pipeline (2015): Drugs In Clinical Trials

Depression: My Story About the Power of Medication

Why We’ve Probably Overestimated the Benefits of Psychotherapy for Depression

The Mental Illness Drunk Tank

Ketamine: Life Saver or Club Drug?


 

Have a great week!

Tags: , , , ,

Category: Drug Development, Mood Disorders, Psychiatry, Psychopharmacology, The Neuroscience Report

Leave a Reply